Airway epithelium in lung transplantation: a potential actor for post-transplant complications?

J Milesi, D Gras, P Chanez… - European Respiratory …, 2024 - publications.ersnet.org
Lung transplantation, a critical intervention for end-stage lung diseases, is frequently
challenged by post-transplant complications. Indeed, primary graft dysfunction, anastomotic …

The diagnosis and management of chronic lung allograft dysfunction

GM Verleden, JMH Hendriks… - Current Opinion in …, 2024 - journals.lww.com
The diagnosis and management of chronic lung allograft dysfu... : Current Opinion in Pulmonary
Medicine The diagnosis and management of chronic lung allograft dysfunction : Current …

Favorable effect of CD26/DPP-4 inhibitors on postoperative outcomes after lung transplantation: A propensity-weighted analysis

Y Yamada, T Sato, H Oda, N Harada… - The Journal of Heart and …, 2024 - Elsevier
Background We have shown the efficacy of CD26/dipeptidyl peptidase 4 (CD26/DPP-4)
inhibitors, antidiabetic agents, in allograft protection after experimental lung transplantation …

[PDF][PDF] Proteomic analysis of transbronchial biopsy tissue reveals a distinct proteome and mechanistic pathways in high-grade eosinophilic inflammation after lung …

E Tahmasbpour, A Philp, T Cree, V Sivasubramaniam… - 2024 - scholar.archive.org
Background: Eosinophilic (EOS) in ammation is associated with acute cellular rejection
(ACR) and an increased risk of chronic lung allograft dysfunction (CLAD) after lung …

Modifications de l'épithélium bronchique survenant au cours de la dysfonction chronique du greffon pulmonaire et rôle des microparticules leucocytaires

B Renaud-Picard - 2023 - theses.hal.science
La dysfonction chronique du greffon pulmonaire (CLAD) est la principale complication
limitant la survie à long-terme après une transplantation pulmonaire, avec plusieurs …